Form 8-K - Current report:
SEC Accession No. 0001193125-22-156879
Filing Date
2022-05-23
Accepted
2022-05-23 08:37:31
Documents
14
Period of Report
2022-05-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d304590d8k.htm   iXBRL 8-K 26814
2 EX-99.1 d304590dex991.htm EX-99.1 95571
6 GRAPHIC g304590dsp05.jpg GRAPHIC 3929
  Complete submission text file 0001193125-22-156879.txt   258856

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cbio-20220519.xsd EX-101.SCH 2894
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20220519_lab.xml EX-101.LAB 17996
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20220519_pre.xml EX-101.PRE 11287
8 EXTRACTED XBRL INSTANCE DOCUMENT d304590d8k_htm.xml XML 3335
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 22949661
SIC: 2834 Pharmaceutical Preparations